Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VM.

Neuron. 1999 Nov;24(3):751-62.

2.

Amyotrophic lateral sclerosis/parkinsonism dementia complex: transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam.

Trojanowski JQ, Ishihara T, Higuchi M, Yoshiyama Y, Hong M, Zhang B, Forman MS, Zhukareva V, Lee VM.

Exp Neurol. 2002 Jul;176(1):1-11. Review.

PMID:
12093078
3.

Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease.

Lee VM, Trojanowski JQ.

Neurology. 2001 Jun;56(11 Suppl 4):S26-30. Review.

PMID:
11402147
4.

In vivo analysis of wild-type and FTDP-17 tau transgenic mice.

Götz J, Barmettler R, Ferrari A, Goedert M, Probst A, Nitsch RM.

Ann N Y Acad Sci. 2000;920:126-33. Review.

PMID:
11193141
5.

Frontotemporal dementia and tauopathy.

Yoshiyama Y, Lee VM, Trojanowski JQ.

Curr Neurol Neurosci Rep. 2001 Sep;1(5):413-21. Review.

PMID:
11898551
6.

Analysis of tauopathies with transgenic mice.

Hutton M, Lewis J, Dickson D, Yen SH, McGowan E.

Trends Mol Med. 2001 Oct;7(10):467-70. Review.

PMID:
11597522
7.

The neuropathological spectrum of neurodegenerative tauopathies.

Tolnay M, Probst A.

IUBMB Life. 2003 Jun;55(6):299-305. Review.

8.

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Spillantini MG, Van Swieten JC, Goedert M.

Neurogenetics. 2000 Mar;2(4):193-205. Review.

PMID:
10983715
9.

[Neurodegeneration and inflammation: analysis of a FTDP-17 model mouse].

Yoshiyama Y.

Rinsho Shinkeigaku. 2008 Nov;48(11):910-2. Review. Japanese.

PMID:
19198115
10.

Tau and axonopathy in neurodegenerative disorders.

Higuchi M, Lee VM, Trojanowski JQ.

Neuromolecular Med. 2002;2(2):131-50. Review.

PMID:
12428808
11.

Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.

Chen F, David D, Ferrari A, Götz J.

Curr Drug Targets. 2004 Aug;5(6):503-15. Review.

PMID:
15270197
12.

Frontotemporal dementia with tau pathology.

Gasparini L, Terni B, Spillantini MG.

Neurodegener Dis. 2007;4(2-3):236-53. Review.

PMID:
17596718
13.

The role of tau phosphorylation and cleavage in neuronal cell death.

Chun W, Johnson GV.

Front Biosci. 2007 Jan 1;12:733-56. Review.

PMID:
17127334
14.

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.

Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F.

Exp Gerontol. 2000 Sep;35(6-7):831-41. Review.

PMID:
11053674
15.

Tau and transgenic animal models.

Götz J.

Brain Res Brain Res Rev. 2001 Jul;35(3):266-86. Review.

PMID:
11423157
16.

Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.

Zilka N, Korenova M, Novak M.

Acta Neuropathol. 2009 Jul;118(1):71-86. doi: 10.1007/s00401-009-0499-y. Epub 2009 Feb 24. Review.

PMID:
19238406
17.

The role of tau in Alzheimer's disease.

Trojanowski JQ, Lee VM.

Med Clin North Am. 2002 May;86(3):615-27. Review.

PMID:
12168561
18.

Brief update on different roles of tau in neurodegeneration.

Ittner A, Ke YD, van Eersel J, Gladbach A, Götz J, Ittner LM.

IUBMB Life. 2011 Jul;63(7):495-502. doi: 10.1002/iub.467. Review.

19.

Mutations causing neurodegenerative tauopathies.

Goedert M, Jakes R.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):240-50. Review.

20.

Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

Julien C, Bretteville A, Planel E.

Methods Mol Biol. 2012;849:473-91. doi: 10.1007/978-1-61779-551-0_32. Review.

PMID:
22528110

Supplemental Content

Support Center